36
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Are implantable cardioverter-defribrillators always superior to amiodarone?

Pages 2111-2114 | Published online: 02 Mar 2005

Bibliography

  • STRICKBERGER SA, HUMMEL J,BARTLETT TG et al: Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic cardiomyopathy and asymptomatic nonsustained VT — AMIOVERT. I Am. Cell. Cardin]. (2003) 41:1707–1712.
  • DOVAL HC, NUL DR, GRANCELLI HO et at Randomised trial of low-dose amiodarone in severed congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficienca Cardiaca en Argentina (GESICA). Lancet (1994) 344:493–438.
  • SINGH SN, FLETCHER RD, FISHER SG et at Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl.' Med. (1995) 333:77–82.
  • MOSS AJ, HALL WJ, CANNON DS et al: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicentre Automatic Defibrillator Implantation Trial Investigators. N Engl. Med. (1996) 335:1933–1940.
  • BUXTON AE, LEE KL, FISHER JD et al: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl. Med. (1999) 341:1882–1890.
  • THE ANTIARRHYTMICS VERSUS IMPLANTABLE DEFIBRILLATOR (AVID) INVESTIGATORS: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmia. N Engl. I Med. (1999) 337:1576–1583.
  • PITT B, ZANNAD F, REMME WJ et al:The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl.' Med. (1999) 341:709–717.
  • PITT B, REMME W, ZANNAD F et al.:Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl.' Med. (2003) 348:1309–1321.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.